EXECUTION VERSION STOCK PURCHASE AGREEMENT by and among Masthercell Global Inc., Orgenesis Inc., and GPP-II Masthercell, LLC Dated June 28, 2018 Page -i- Page -ii- Page -iii- EXHIBITS AND SCHEDULES Exhibit A — Advisory Services Agreements Exhibit B —...Stock Purchase Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis Stock Purchase Agreement (this “Agreement”) is entered into on June 28, 2018 by and among GPP-II Masthercell, LLC, a Delaware limited liability company (“Investor”), Masthercell Global Inc., a Delaware corporation (the “Company”), and Orgenesis Inc., a Nevada corporation (“Orgenesis Parent”). Investor, the Company, and Orgenesis Parent are referred to collectively herein as the “Parties” and individually as a “Party”.
STOCK PURCHASE AGREEMENT by and among Masthercell Global Inc., Orgenesis Inc., and GPP-II Masthercell, LLC Dated June 28, 2018Stock Purchase Agreement • June 29th, 2018 • Orgenesis Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 29th, 2018 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is entered into on June 28, 2018 by and among GPP-II Masthercell, LLC, a Delaware limited liability company (“Investor”), Masthercell Global Inc., a Delaware corporation (the “Company”), and Orgenesis Inc., a Nevada corporation (“Orgenesis Parent”). Investor, the Company, and Orgenesis Parent are referred to collectively herein as the “Parties” and individually as a “Party”.